Literature DB >> 18770425

Anti-viral immunity against Marek's disease virus infected chicken kidney cells.

H Kodama1, C Sugimoto, F Inage, T Mikami.   

Abstract

The mechanism of immunity conferred by herpesvirus of turkeys (HVT) was investigated using Marek's disease virus (MDV)-infected chicken kidney cell (CKC) cultures as target cells. Peripheral blood lymphocytes (PBL) from normal or HVT-vaccinated chickens killed MDV-infected target cells in the presence of anti-MDV or anti-HVT serum, whereas normal lymphocytes and HVT-sensitised lymphocytes themselves had no specific cytotoxic effect. Cell-mediated cytotoxicity of PBL from HVT-vaccinated chicken was exhibited specifically against HVT-infected CKC, and that of PBL from chickens inoculated with MDV was exhibited against MDV-infected CKC. From these results, it was concluded that antibody-dependent cellular cytotoxicity to MDV-infected cells may contribute to resistance to Marek's disease induced by HVT vaccination.

Entities:  

Year:  1979        PMID: 18770425     DOI: 10.1080/03079457908418325

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  3 in total

1.  Establishment of a variant type of turkey herpesvirus which releases cell-free virus into the culture medium in large quantities. Brief report.

Authors:  S Yachida; T Kondo; K Hirai; H Izawa; T Mikami
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

2.  Marek's disease virus infection of phagocytes: a de novo in vitro infection model.

Authors:  Pankaj Chakraborty; Lonneke Vervelde; Robert G Dalziel; Peter S Wasson; Venugopal Nair; Bernadette M Dutia; Pete Kaiser
Journal:  J Gen Virol       Date:  2017-05-26       Impact factor: 3.891

3.  Macrophages from Susceptible and Resistant Chicken Lines have Different Transcriptomes following Marek's Disease Virus Infection.

Authors:  Pankaj Chakraborty; Richard Kuo; Lonneke Vervelde; Bernadette M Dutia; Pete Kaiser; Jacqueline Smith
Journal:  Genes (Basel)       Date:  2019-01-22       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.